Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-22-082798
Filing Date
2022-03-23
Accepted
2022-03-23 16:37:27
Documents
11
Effectiveness Date
2022-03-23

Document Format Files

Seq Description Document Type Size
1 POSASR d280081dposasr.htm POSASR 581821
2 EX-5.1 d280081dex51.htm EX-5.1 21425
3 EX-5.2 d280081dex52.htm EX-5.2 27519
4 EX-23.2 d280081dex232.htm EX-23.2 1516
5 EX-FILING FEES d280081dexfilingfees.htm EX-FILING FEES 72278
6 GRAPHIC g280081g03s03.jpg GRAPHIC 53250
7 GRAPHIC g280081g43g40.jpg GRAPHIC 8117
8 GRAPHIC g280081g43s48.jpg GRAPHIC 6622
9 GRAPHIC g280081g51s75.jpg GRAPHIC 37702
10 GRAPHIC g280081g52s52.jpg GRAPHIC 38254
11 GRAPHIC g280081g75s75.jpg GRAPHIC 43520
  Complete submission text file 0001193125-22-082798.txt   949950
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-253851 | Film No.: 22763619
SIC: 2834 Pharmaceutical Preparations